Warning: Undefined array key "uploads/position_papers/" in /customers/3/1/3/infmed.dk/httpd.www/site/pages/search.php on line 313 Warning: Undefined array key "uploads/position_papers/" in /customers/3/1/3/infmed.dk/httpd.www/site/pages/search.php on line 313

Søgning på udtrykket 'covid-19' giver 99 resultater


Dokumenter [11] Sider [2] Kalender [28] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [11]

Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.

Udarbejdet i samarbejde mellem DSOG og Dansk Infektionsmedicinsk Selskab

Invitation til møde den 20. maj 2022

I forbindelse med Sundhedsstyrelsens udgivelse af "Personer med øget risiko ved COVID-19. Fagligt grundlag", har DSI beskrevet følgende specialespecifikke patienter med øget risiko for et alvorligt COVID-19 sygdomsforløb.

COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed

DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.

Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale

Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.

Sotrovimab anbefales ikke længere til behandling af tidlig COVID-19 med Omicron BA.2

Sider [2]

…andling ved HIV og hepatitis B og C, HIV behandling af gravide, HIV post exposure profylakse (PEP), Pre-exposure profylakse mod HIV (PrEP), Borrelia: Anne-Mette Lebech, Sigurdur Skarphedinsson Borrelia klaringsrapport, COVID-19: Marie Helleberg/Jens Lundgren, Lothar Wiese, Michael Dalager-Pedersen, Merete Storgaard, Isik Somuncu Johansen og Gitte Kronborg COVID-19 retningslinje, Cystisk fibrose (SST's arbejdsgruppe til eftersyn af området vedrørende c…


Kalender [28]

14. december, Online
21. marts, Aarhus Universitetshospital, Skejby
7. december 2021, Online
4. november 2021, Online
21. september 2021, Online
31. august 2021, Holst Auditoriet, Mærsk Tårnet, København
16. juni 2021, Online
27. maj 2021, Online
7. maj 2021, Online
13. april 2021, Online
23. marts 2021, Online
22. marts 2021, Online
16. marts 2021, Online
3. februar 2021, Online
19. januar 2021, Online
30. december 2020, Online
9. oktober 2020, Århus og online
18. juni 2020, Aflyst på grund af COVID-19
3. juni 2020, Mødet udskudt på grund af COVID-19
24. marts 2020, København

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
AIDS
25.11.2022
Objectives: . Many vaccines require higher/additional doses or adjuvants to provide adequate protection for people living with HIV (PLWH). Our objective was to compare COVID-19 vaccine immunogenicity in PLWH to HIV-negative individuals. Design: . In a Canadian multi-centre prospective, observational cohort of PLWH receiving ≥2 COVID-19 vaccinations, we measured vaccine-induced immunity at three and six months post 2nd and one month post 3rd doses. Methods: . The primary outcome was the percentage of PLWH …
Clinical Microbiology and Infection
25.11.2022
First cases of the ongoing COVID-19 pandemic were identified in France in January 2020 and on February 28, 2020, in Corsica, an island situated in the Mediterranean Sea. A major outbreak hit early the ultra-peripheral region in the following of three imported cases returning from religious gathering in mainland France. Corsica has one of the oldest population in the world and a limited beds capacity in its 2 hospitals. Therefore, the healthcare systems were rapidly overwhelmed by influx of difficult-to-tran…
BMC Infectious Diseases
24.11.2022
…omplication in patients with seasonal viral respiratory tract infections and are associated with poor prognosis, increased risk of intensive care unit admission and 29–55% mortality. Yet, there is limited data on the burden of bacterial infections among COVID-19 patients in Africa, where underdeveloped healthcare systems are likely to play a pertinent role in the epidemiology of the COVID-19 pandemic. Here, we evaluated the etiologies, antimicrobial resistance profiles, risk factors, and outcomes of bacte…
BMC Infectious Diseases
24.11.2022
. Abstract. . Background. The efficacy of early treatment with convalescent plasma in patients with COVID-19 is debated. Nothing is known about the potential effect of other plasma components other than anti-SARS-CoV-2 antibodies. . . . Methods. To determine whether convalescent or standard plasma would improve outcomes for adults in ea…
Journal of Infectious Diseases
23.11.2022
AbstractBackgroundWe assessed COVID-19 vaccination impact on illness severity among adults hospitalized with COVID-19 August 2021–March 2022.MethodsWe evaluated differences in intensive care unit (ICU) admission, in-hospital death, and length of stay among vaccinated (2 or 3 mRNA vaccine doses) versus unvaccinated patients aged ≥18 years hospitalized for ≥24 hours with COVID-19-like illness (CLI) and positive SARS-CoV-2 molecular testing. We calculated odds ratios for ICU admission and death and sub…
New England Journal of Medicine
23.11.2022
New England Journal of Medicine, Volume 387, Issue 21, November 2022.
Proceedings of the National Academy of Sciences
23.11.2022
Proceedings of the National Academy of Sciences, Volume 119, Issue 48, November 2022.
Journal of the American Medical Association
23.11.2022
The first-in-human study of intranasal COVID-19 vaccination with an adenovirus-vector vaccine did not induce a consistent mucosal antibody response or a strong systemic response.
Clinical Infectious Diseases
22.11.2022
AbstractBackgroundWe report primary results of a phase 3 trial of AZD7442 (tixagevimab/cilgavimab) for post-exposure prophylaxis to prevent symptomatic coronavirus disease 2019 (COVID-19)MethodsAdults without prior SARS-CoV-2 infection or COVID-19 vaccination were enrolled within 8 days of exposure to a SARS-CoV-2–infected individual and randomized 2:1 to a single 300-mg AZD7442 dose (one 1.5-mL intramuscular injection each of tixagevimab and cilgavimab consecutively) or placebo. Primary endpoints were sa…
Journal of Infectious Diseases
21.11.2022
AbstractWe assessed changes in sexual behaviour among people with HIV (PWH) over 20 years. Condom use with stable partners steadily declined from over 90% to 29% since the Swiss U = U statement with similar trajectories between men who have sex with men (MSM) and heterosexuals. Occasional partnership remained higher among MSM compared to heterosexuals even during COVID-19 social distancing.
Journal of Infectious Diseases
21.11.2022
AbstractBackgroundThe impact variant-specific immune evasion and waning protection have on declining COVID-19 vaccine effectiveness remains unclear. Using whole-genome-sequencing (WGS), we examined the contribution of these factors on the decline observed following the introduction of the Delta variant. Further, we evaluated the utility of calendar-period-based classification as an alternative to WGS.MethodsWe conducted a test-negative-case-control study among people who received SARS-CoV-2 RT-PCR testing i…
Proceedings of the National Academy of Sciences
21.11.2022
Proceedings of the National Academy of Sciences, Volume 119, Issue 48, November 2022.
International Journal of Infectious Diseases
21.11.2022
The omicron variant (B.1.1.529) of severe acute respiratory virus 2 (SARS-CoV-2) was first identified in November 2021 (Viana et al., 2022) and has dramatically increased the transmission of Coronavirus disease 2019 (COVID-19) globally. The COVID-19 vaccine protects against serious disease, hospitalization, and death. However, vaccination does not entirely prevent infection and transmission to others. Massive two-dose vaccination campaigns cannot prevent breakthrough infections caused by the variants (Cele …
BMC Infectious Diseases
18.11.2022
…kground. Our understanding of the influence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on bacterial colonization in the children’s upper nasopharyngeal tract during the coronavirus infectious disease (COVID-19) pandemic is limited. This study aimed to determine whether there were any differences in bacterial colonization between asymptomatic children with or without a positive SARS-CoV-2 quantitative reverse transcriptase-polymerase chain reaction (RT-q…
Immunity
18.11.2022
Publication date: Available online 17 November 2022. Source: Immunity. Author(s): Iker Valle Aramburu, Dennis Hoving, Spyros I. Vernardis, Martha Tin, Marianna Ioannou, Mia I. Temkin, Nathalia M. De Vasconcelos, Vadim Demichev, Elisa Theresa Helbig, Lena Lippert, Klaus Stahl, Matthew White, Helena Radbruch, Jana Ihlow, David Horst, Scott T. Chiesa, John E. Deanfield, Sascha David, Christian Bode, Florian Kurth.
BMJ Open
17.11.2022
. Background. Globally, there is a scarcity of effective treatments for SARS-CoV-2 infections (causing COVID-19). Repurposing existing medications may offer the best hope for treating patients with COVID-19 to curb the pandemic. IMU-838 is a dihydroorotate dehydrogenase inhibitor, which is an effective mechanism for antiviral effects against respiratory viruses. When used synergistically with oseltamivir, therapeutic effects have been observed against influenza and SARS-CoV-2 in rodents. The IMU-838 and Ose…
BMJ Open
17.11.2022
. Objectives. COVID-19 has differentially affected countries, with health infrastructure and other related vulnerability indicators playing a role in determining the extent of its spread. Vulnerability of a geographical region to COVID-19 has been a topic of interest, particularly in low-income and middle-income countries like India to assess its multifactorial impact on incidence, prevalence or mortality. This study aims to construct a statistical analysis pipeline to compute such vulnerability indices and…
BMJ Open
17.11.2022
. Objective. We undertook a systematic review of strategies adopted to scale up COVID-19 testing in countries across income levels to identify successful approaches and facilitate learning. Methods. Scholarly articles in English from PubMed, Google scholar and Google search engine describing strategies used to increase COVID-19 testing in countries were reviewed. Deductive analysis to allocate relevant text from the reviewed publications/reports to the a priori themes was done. Main results. The review cove…
BMJ Open
17.11.2022
. Objective. Migrants and ethnic minority groups have been disproportionately impacted by COVID-19 and have lower levels of vaccine uptake in some contexts. We aimed to determine the extent and nature of social media use in migrant and ethnic minority communities for COVID-19 information, and implications for preventative health measures including vaccination intent and uptake. Design. A systematic review of published and grey literature following the Preferred Reporting Items for Systematic Reviews and Met…
Clinical Infectious Diseases
17.11.2022
AbstractTixagevimab and cilgavimab treatment was associated with higher rates of cardiovascular events in a post-hoc analysis of a phase 3 trial. In this large population-based propensity-matched study, we found no increased risk of cardiovascular events up to 90 days after tixagevimab and cilgavimab administration, including in patients with pre-existing cardiovascular disease.

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Statens Serum Institut
25.11.2022
Der er fald i smitten med covid-19, efter der var en opbremsning i sidste uge. Men der er fortsat et højt antal smittede med RS-virus. Det er hovedpunkterne i ugens tendensrapport fra Statens Serum Institut (SSI).
Medscape Infectious Diseases
23.11.2022
Scientists have found that COVID-19 causes brain 'abnormalities' even 6 months after symptoms are gone. . WebMD Health News
Medscape Infectious Diseases
23.11.2022
"Monoclonals had their day, like the Model T or the biplane," Carl Dieffenbach, director of the Division of AIDS at the National Institutes of Health and lead of the NIH's Antiviral Program for Pandemics. . WebMD Health News
Medscape Infectious Diseases
23.11.2022
Clinicians should consider age, sex, and vaccine type when accounting for vaccination risks, according to the authors of an observational study. . Medscape Medical News
Statens Serum Institut
23.11.2022
Danskere med lavt D-vitamin niveau, der blev smittet med covid-19, blev ramt hårdere af virussen end danskere med tilstrækkeligt D-vitamin niveau. Det viser et forskningsprojekt fra Statens Serum Institut, der har undersøgt sammenhængen mellem D-vitamin niveau og covid-19 sværhedsgrad hos smittede.
Morbidity and Mortality Weekly Report (MMWR)
23.11.2022
This report describes how eligible adults prescribed Paxlovid were 51% less likely to be hospitalized with COVID-19, regardless of vaccination status.
Medscape Infectious Diseases
22.11.2022
Patients with nasopharyngeal cancer who received the Chinese Sinovac COVID-19 vaccine did better on immune checkpoint inhibitor therapy compared with unvaccinated patients, early data suggest. . Medscape Medical News
ECDC COVID-19 updates
22.11.2022
This generic protocol for ECDC studies describes the design and methods for a prospective multi-country cohort study of hospital-based healthcare workers (HCWs) to evaluate the effectiveness of COVID-19 vaccine in preventing laboratory-confirmed SARS-CoV-2 infection.
ECDC COVID-19 updates
22.11.2022
This document reports on one of ECDC’s multi-country studies in the hospital setting to measure product-specific COVID-19 VE against any laboratory-confirmed SARS-CoV-2 infection among healthcare workers (HCWs) eligible for vaccination.
Statens Serum Institut
18.11.2022
Antallet af smittede med luftvejssygdommen RS-virus stiger fortsat. Samtidig ser SARS-CoV-2 ud til at stabilisere sig efter fire ugers fald i smitten. Det viser ugens tendensrapport.
Morbidity and Mortality Weekly Report (MMWR)
18.11.2022
This report describes COVID-19 vaccination coverage for children less than 5 years old.
Morbidity and Mortality Weekly Report (MMWR)
18.11.2022
This report describes perception of local COVID-19 transmission and preventive measures in Illinois and Michigan.
Medscape Infectious Diseases
16.11.2022
The new prime minister ended mandatory vaccination for healthcare workers and is considering reducing the quarantine period for positive cases; experts disagree. . Medscape Medical News
Statens Serum Institut
16.11.2022
Statens Serum Institut forventer en faldende til stabil udvikling af covid-19-epidemien over de kommende måneder. Fremskrivningen baserer sig på viden om immuniteten i befolkningen, effekten af boostervaccinerne og viden om de cirkulerende varianter.
Medscape Infectious Diseases
15.11.2022
The number of new COVID cases has grown by 8% over the last 14 days while the number of new hospitalizations has gone up 3% over that time period. . WebMD Health News
ProMED
11.11.2022
COVID-19 -- Researchers in Britain say they have used genetic sequencing to help cure a man who was infected with the coronavirus for more than 411 days.The 59-year-old patient, who had a weakened immune system due to a kidney transplant and the use of an immunosuppressant drug, initially tested positive in December 2020.After further tests in February 2021 and January 2022 came back positive, the team in London carried out a genetic analysis of the virus, which showed that the same strain was
Morbidity and Mortality Weekly Report (MMWR)
10.11.2022
This report describes COVID-19 hospitalizations among infants younger than six months old.
Morbidity and Mortality Weekly Report (MMWR)
10.11.2022
This report describes recommendations from the Advisory Committee on Immunization Practices for use of bivalent COVID-19 vaccines.
Statens Serum Institut
10.11.2022
For fjerde uge i træk ses der et fald i antallet af personer, der er bekræftet smittet med SARS-CoV-2 og færre bliver indlagt. Det er hovedpunkterne i ugens tendensrapport fra Statens Serum Institut (SSI).
Medscape Infectious Diseases
10.11.2022
'We have come a long way, and this is definitely cause for optimism. But we continue to call on all governments, communities, and individuals to remain vigilant,' said Tedros Adhanom Ghebreyesus. . WebMD Health News

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2022 Dansk Selskab for Infektionsmedicin

CVR: 33634307

version: 2.11.0 ● PHP version 8.0.26 ● design: Christian Philip Fischer

Side indlæst på 0.504 s

Cookies og privatliv